Heartflow (HTFL) closed at $52.40 on November 6, 2026, up 0.9% from the previous close, on volume of 919,535 shares (30-day average 1,584,192).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 21, 2026 | Condor Ratio With Puts | 20-Nov-2640[19x] : 45[19x] : 50[24x] : 55[24x] P | 430 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
HeartFlow, Inc. (HTFL) Receives a Buy from Canaccord Genuity
TipRanks (Wed, 4-Nov 9:03 AM ET)
Globe Newswire (Mon, 2-Nov 8:00 AM ET)
Globe Newswire (Sun, 1-Nov 1:45 PM ET)
Boston Scientific announces results for third quarter 2026
PRNewswire (Wed, 28-Oct 6:31 AM ET)
Market Chameleon (Tue, 20-Oct 7:57 AM ET)
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026
Globe Newswire (Mon, 19-Oct 4:01 PM ET)
Globe Newswire (Fri, 28-Aug 2:48 AM ET)
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
Globe Newswire (Thu, 27-Aug 4:01 PM ET)
Heartflow’s Q2 Revenue Surges 48% as Annual Guidance Raised: Gross Margins Hit Record Highs
Market Chameleon (Fri, 14-Aug 6:31 AM ET)
Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Globe Newswire (Thu, 13-Aug 4:01 PM ET)
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
Heartflow trades on the NASDAQ stock market under the symbol HTFL.
As of November 6, 2026, HTFL stock price climbed to $52.40 with 919,535 million shares trading.
HTFL has a beta of 1.52, meaning it tends to be more sensitive to market movements. HTFL has a correlation of 0.04 to the broad based SPY ETF.
HTFL has a market cap of $4.56 billion. This is considered a Mid Cap stock.
Last quarter Heartflow reported $53 million in Revenue and -$.07 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $.08.
The top ETF exchange traded funds that HTFL belongs to (by Net Assets): VTI, IWM, VB, VBR, IWO.
HTFL has outperformed the market in the last year with a return of +51.9%, while the SPY ETF gained +10.8%. In the last 3 month period, HTFL beat the market returning +92.7%, while SPY returned -4.1%. However, in the most recent 2 weeks HTFL has underperformed the stock market by returning -7.6%, while SPY returned -3.2%.
HTFL support price is $49.63 and resistance is $54.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HTFL shares will trade within this expected range on the day.
